Risk factor control in the hypertensive patients with chronic ischemic heart disease attended in cardiologic outpatient clinics. The CINHTIA study

被引:14
作者
Barrios, V.
Escobar, C.
Bertomeu, V.
Murga, N.
de Pablo, C.
Calderon, A.
机构
[1] Sección de Cardiología Clínica Y Extrahospitalaria, Sociedad Española de Cardiología
[2] Sección de Hipertensión Arterial, Sociedad Española de Cardiología
[3] Sección de Cardiología Preventiva Y Rehabilitación, Sociedad Española de Cardiología
[4] Instituto de Enfermedades del Corazón, Hospital Ramón Y Cajal, 28034 Madrid, Ctra. de Colmenar km 9
来源
REVISTA CLINICA ESPANOLA | 2008年 / 208卷 / 08期
关键词
hypertension; cardiologist setting; chronic ischemic heart disease;
D O I
10.1157/13126342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The CINHTIA study is a cross-sectional and multicentre survey designed to assess the clinical management of the hypertensive outpatients with chronic ischemic heart disease attended by cardiologists. Patients and methods. Patients >= 18 years, with a diagnosis of hypertension and chronic ischemic heart disease, were included in the study. Patients with an acute coronary syndrome within the three months prior to the inclusion were excluded. Good blood pressure (BP) control was considered < 140/90 mmHg, < 130/80 mmHg for diabetics (ESH-ESC 2003). LDL cholesterol (LDL-c) < 100 mg/dl (NCEP-ATP III) and fasting glucose between 90 and 130 mg/dl (ADA 2005) were considered as good control rates. Results. A total of 2,024 patients (66.8 +/- 10.1 years; 31.7% women) were included in the study. Systolic BP was 142.7 +/- 17.9 mmHg and diastolic BP 81.8 +/- 11.3 mmHg. 78.4% of the patients had dyslipidemia and 32.3% diabetes. Almost all the patients (99.7%) were taking at least one antihypertensive drug, beta blockers being the most frequent (67.1%). A total of 74.9% of the patients were taking lipid lowering drugs and 27.9% antidiabetics. BP was controlled in 40.5% of the patients, LDL-c in 30.6% of the dyslipidemic subgroup and fasting glucose in 26.6% of the diabetics. Conclusions. In this high-risk population, the control rates of risk factors continues to remain low even though the majority of patients were taking several drugs,.
引用
收藏
页码:400 / 404
页数:5
相关论文
共 15 条
[1]  
*AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS1
[2]   Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain.: The PRESCOT study [J].
Barrios, V. ;
Escobar, C. ;
Llisterri, J. L. ;
Calderon, A. ;
Alegria, E. ;
Muniz, J. ;
Matali, A. .
REVISTA CLINICA ESPANOLA, 2007, 207 (04) :172-178
[3]   Evolution of blood pressure control in Spain [J].
Barrioso, Vivencio ;
Banegas, Jose R. ;
Ruilope, Luis M. ;
Rodicio, Jos L. .
JOURNAL OF HYPERTENSION, 2007, 25 (09) :1975-1977
[4]   International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [J].
Bhatt, DL ;
Steg, PG ;
Ohman, EM ;
Hirsch, AT ;
Ikeda, Y ;
Mas, JL ;
Goto, S ;
Liau, CS ;
Richard, AJ ;
Röther, J ;
Wilson, PWF ;
Andersen-Dalheim, H ;
Anderson, P ;
Anell, B ;
Arber, S ;
Armstrong, K ;
Arnot, D ;
Baldam, A ;
Barratt, I ;
Barresi, S ;
Beder, J ;
Benson, M ;
Bergman, F ;
Best, J ;
Bhasim, R ;
Bovell, G ;
Bowman, N ;
Brkic, M ;
Bromberger, D ;
Brown, D ;
Brown, J ;
Brownstein, M ;
Bruce, A ;
Buonopane, J ;
Burns, S ;
Butler, A ;
Byrne, D ;
Carson, J ;
Cassimatis, P ;
Chaffey, G ;
Chambers, D ;
Chan, WJ ;
Chan, B ;
Cheatham, J ;
Chen, R ;
Cheong, B ;
Cheung, C ;
Chin, J ;
Chiu, A ;
Choo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02) :180-189
[5]   Meta-analysis: Secondary prevention programs for patients with coronary artery disease [J].
Clark, AM ;
Harding, L ;
Vandermeer, B ;
McAlister, FA .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) :659-672
[6]  
Díez JMB, 2005, REV ESP CARDIOL, V58, P367, DOI 10.1157/13073893
[7]   Clinical presentation, diagnosis and treatment of four cases of Cor triatriatum [J].
González, JJS ;
Osuna, JGG ;
Herguedas, EM ;
González, ES ;
Peralta, LJP ;
Mena, JS .
REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (08) :1013-1016
[8]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[9]  
Grupo Barbanza para el Estudio de las Enfermedades Cardiovasculares, 2003, REV CLIN ESP, V203, P570
[10]  
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8